⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Merit Medical gets FDA nod for new cancer surgery system

EditorRachael Rajan
Published 02/15/2024, 10:22 AM
© Reuters.

SOUTH JORDAN, Utah - Merit Medical Systems , Inc. (NASDAQ: NASDAQ:MMSI), a healthcare technology company, has announced receiving FDA 501(k) clearance for its SCOUT MD Surgical Guidance System. This system is designed to improve the precision of surgeries for breast and other soft tissue cancers by enabling the implantation of up to four different reflector configurations to pinpoint tumor locations.

The SCOUT MD system aims to facilitate more accurate excisions while minimizing damage to surrounding healthy tissue. This could potentially decrease the likelihood of patients needing re-excision, which is a second surgery often required when initial margins are not clear. According to Dr. John Vincent Kiluk, a Breast Surgical Oncologist, the new technology allows surgeons to delineate the edges of resection better, which should improve the ability to obtain adequate margins on larger tumors.

Merit's introduction of the SCOUT MD Surgical Guidance System expands its oncology portfolio, which includes the SCOUT Radar Localization System and the SAVI Brachy System. The company's focus on innovation is underscored by its distribution of over 500,000 devices for patient procedures as of January 2024, gathering real-world evidence to enhance oncology care.

The development of SCOUT MD is particularly significant given that breast cancer is the most prevalent cancer worldwide, with an estimated 2.3 million women diagnosed in 2020. Lumpectomy, a common treatment option, leads to repeat surgeries in 20% to 30% of cases due to inadequate margins from the initial surgery.

Merit Medical, founded in 1987, specializes in the development, manufacture, and distribution of disposable medical devices for various medical procedures, including cardiology, radiology, and oncology. The company employs around 7,000 people globally and is dedicated to continuing innovation in healthcare technology to enhance patient experiences and outcomes.

This announcement is based on a press release statement from Merit Medical Systems, Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.